NEW YORK (GenomeWeb News) - Rosetta Genomics has licensed from Rockefeller University the right to access nearly 180 of its microRNAs, Rosetta said today.
Rosetta said it will add these microRNAs to its existing microRNA database, which could arm it with additional biomarker candidates for its diagnostic development programs.
Rosetta has discovered nearly 360 biologically validated human microRNAs and the Rockefeller agreement will enable it to study 530 of the 660 publicly confirmed microRNA genes in the entire human genome, the company said.
The company will use the microRNAs to "potentially advance multiple" research development programs targeting new microRNA-based diagnostic tools for a "variety" of diseases.
Terms of the agreement call for Rosetta Genomics to pay Rockefeller University an initiation fee as well as maintenance fees and royalties.